Kemler M A, Barendse G A, van Kleef M, Egbrink M G
Department of Surgery of Maastricht University Hospital, Maastricht, The Netherlands.
Anesthesiology. 2000 Jun;92(6):1653-60. doi: 10.1097/00000542-200006000-00024.
Spinal cord stimulation (SCS) is known to relieve pain in patients with complex regional pain syndrome (CRPS) and, in general, to cause vasodilation. The vasodilatory effect of SCS is hypothesized to be secondary to inhibition of sympathetically mediated vasoconstriction, or through antidromic impulses resulting in release of vasoactive substances. The aim of the present study was to assess whether pain relief in CRPS after SCS is, in fact, dependent on vasodilation. In addition, we tried to determine which of the potential mechanisms may cause the vasodilatory effect that is generally found after SCS.
Twenty-four of 36 patients with unilateral CRPS responded to the test of SCS. Twenty-two of these 24 responders (hand, n = 14; foot, n = 8) who had undergone previous sympathectomy were enrolled for the study. In addition, 20 control subjects (10 controls for each extremity) were studied. By means of laser Doppler flowmetry, the skin microcirculation of the patients was measured bilaterally while the SCS system was switched off and while it was activated. Control subjects (n = 20) were tested once only. The ratio of the rest flow at heart level and the dependent position was defined as the vasoconstriction index.
Both in affected hands and feet, patients were found to have lower vasoconstriction indices (P < 0.01) as compared with controls, indicating a decreased sympathetic tone. Applying SCS did not result in any microcirculatory change as compared with baseline or the contralateral clinically unaffected side.
The current study failed to show that SCS influences skin microcirculation in patients with CRPS and a low sympathetic tone. Therefore, we may conclude that pain relief in CRPS due to SCS is possible without vasodilation. Because sympathetic activity was greatly decreased in our patients, these results support the hypothesis that the vasodilation that is normally found with SCS is due to an inhibitory effect on sympathetically maintained vasoconstriction.
已知脊髓刺激(SCS)可缓解复杂性区域疼痛综合征(CRPS)患者的疼痛,且一般会引起血管舒张。SCS的血管舒张作用被认为是继发于对交感神经介导的血管收缩的抑制,或通过逆向冲动导致血管活性物质的释放。本研究的目的是评估SCS后CRPS患者的疼痛缓解是否实际上依赖于血管舒张。此外,我们试图确定哪些潜在机制可能导致SCS后通常出现的血管舒张作用。
36例单侧CRPS患者中有24例对SCS试验有反应。这24例有反应者中的22例(手部14例;足部8例)曾接受过交感神经切除术,被纳入本研究。此外,研究了20名对照受试者(每个肢体10名对照)。通过激光多普勒血流仪,在SCS系统关闭和激活时双侧测量患者的皮肤微循环。对照受试者(n = 20)仅测试一次。将心脏水平和下垂位置的静息血流比值定义为血管收缩指数。
与对照组相比,发现患侧手部和足部的患者血管收缩指数均较低(P < 0.01),表明交感神经张力降低。与基线或对侧临床未受累侧相比,应用SCS未导致任何微循环变化。
当前研究未能表明SCS会影响CRPS且交感神经张力较低患者的皮肤微循环。因此,我们可以得出结论,SCS导致的CRPS疼痛缓解可能与血管舒张无关。由于我们的患者交感神经活动大幅降低,这些结果支持以下假设,即SCS通常出现的血管舒张是由于对交感神经维持的血管收缩的抑制作用。